SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-23-063365
Filing Date
2023-11-14
Accepted
2023-11-14 08:05:08
Documents
13
Period of Report
2023-11-14
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K tlis-20231114.htm   iXBRL 8-K 48965
2 EX-99.1 tlis-ex99_1.htm EX-99.1 153934
  Complete submission text file 0000950170-23-063365.txt   333393

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT tlis-20231114.xsd EX-101.SCH 2457
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT tlis-20231114_lab.xml EX-101.LAB 13904
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT tlis-20231114_pre.xml EX-101.PRE 10222
7 EXTRACTED XBRL INSTANCE DOCUMENT tlis-20231114_htm.xml XML 4889
Mailing Address 1100 ISLAND DRIVE SUITE 101 REDWOOD CITY CA 94065
Business Address 1100 ISLAND DRIVE SUITE 101 REDWOOD CITY CA 94065 650-433-3000
Talis Biomedical Corp (Filer) CIK: 0001584751 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40047 | Film No.: 231401668
SIC: 3826 Laboratory Analytical Instruments